Kymera Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $8.8M | 155k | 56.60 |
| 2025-06-30 | $6.2M | 143k | 43.64 |
| 2025-03-31 | $2.3M | 85k | 27.39 |
| 2024-12-31 | $4.3M | 107k | 40.23 |
| 2024-09-30 | $6.1M | 129k | 47.33 |
| 2024-06-30 | $1.5M | 49k | 29.84 |
| 2024-03-31 | $13M | 320k | 40.20 |
| 2023-12-31 | $9.7M | 382k | 25.46 |
| 2023-09-30 | $5.4M | 390k | 13.90 |
| 2023-06-30 | $8.9M | 385k | 22.99 |
| 2023-03-31 | $11M | 360k | 29.63 |
| 2022-12-31 | $9.8M | 391k | 24.96 |
| 2022-09-30 | $7.7M | 353k | 21.77 |
| 2022-06-30 | $4.6M | 233k | 19.69 |
| 2022-03-31 | $287k | 6.8k | 42.38 |